(1-(5-Hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone

CAS : 335161-21-2

Ref. 3D-KNA16121

Informations sur le produit

• Nom: (1-(5-Hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone

Description

AB-FUBINACA is a synthetic cannabinoid that is an agonist of the cannabinoid receptors. It is used in scientific research to study the endocannabinoid system, as well as for its potential application in treating neurological disorders such as epilepsy and multiple sclerosis. AB-FUBINACA binds to the CB1 receptor, which inhibits adenylate cyclase and lowers cAMP levels. This results in reduced activity of protein kinase A (PKA), which may play a role in seizure generation or epileptogenesis. The compound has been shown to be effective against the symptoms of Parkinson's disease, including tremors and postural instability. AB-FUBINACA also has analgesic properties and can be used to treat chronic pain syndromes such as fibromyalgia, rheumatoid arthritis, and neuropathic pain.
AB-FUBINACA has been detected in urine samples using GC/MS following chromatographic separation with acetonitrile as the mobile

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 357.4 g/mol
• Formule: C₂₄H₂₃NO₂
• Degré de pureté: Min. 95%